Boiron SA (BOI.PA) — Stock Score Summary

Boiron SA (BOI.PA) has a MoatMap StockRank of 99/100 based on Quality (73/100), Value (78/100), and Momentum (54/100) factor scores. The current signal is STRONG BUY. Boiron SA operates in the niche and controversial homeopathic products market. There is no clear macro theme tailwind identified that specifically benefits homeopathic remedies. The company's products lack strong scientific backing, which undermines the 'durable economic moat' and 'pricing power' criteria of the Terry Smith and Warren Buffett lenses. It does not appear to be a quality compounder with an un-copyable advantage in the traditional sense.

Key Financial Metrics

Price$31.66
Market Cap$550M
P/E (TTM)14.26
P/E (Forward)12.58
Price/Book1.18
Return on Equity8.5%
Return on Invested Capital9.3%
Debt/Equity8.02
Gross Margin73.0%
Operating Margin11.6%
Revenue Growth-1.4%
Dividend Yield5.0%
Free Cash Flow$72M

Boiron SA operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (France).

Frequently Asked Questions

What is Boiron SA’s (BOI.PA) StockRank?
MoatMap’s StockRank for Boiron SA (BOI.PA) is 99/100, with a Strong Buy signal. It is a composite of Quality (73), Value (78), and Momentum (54) factor ranks across MoatMap’s 19,000+ stock universe.
Does Boiron SA have an economic moat?
Boiron SA (BOI.PA) has a Quality factor score of 73/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Boiron SA a buy, hold, or sell?
MoatMap’s current signal for Boiron SA (BOI.PA) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Boiron SA in?
Boiron SA (BOI.PA) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (France).
Browse all ranked stocksBOI.PA deep dive reportAI ChampionsHow we score stocksSense-check another stock